ArticleNeurology and therapy2026
Perspectives of Adult Patients and Caregivers on the Management and Challenges Associated with Neurofibromatosis Type 1 and Plexiform Neurofibromas: A Multinational Qualitative Survey.
Article in Neurology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAdults with plexiform neurofibromas arising from neurofibromatosis type 1 (NF1-PN) experience a multifaceted range of clinical symptoms and manifestations, which can impact multiple organ systems and reduce quality of life (QoL). This qualitative study aimed to better understand the experiences of adults and caregivers of adults with NF1-PN and their perspectives on treatment, challenges, and unmet needs across several geographic regions.
methodsWeb-assisted telephone interviews were conducted between January 31, 2024, and April 15, 2024, with adults who had a diagnosis of NF1-PN or with caregivers, focusing on diagnosis, interactions with healthcare professionals (HCPs), transition of care, pain management, and unmet needs. Participants were recruited through HCP referrals, patient organizations, or patient databases.
resultsThe study included 65 patients with NF1-PN and 14 caregivers in Canada, China, France, Germany, Italy, Japan, Spain, and the UK. Patients reported living with multiple NF1-PN-associated morbidities, including pain, disfigurement, psychiatric disorders, and chronic migraines. NF1-PN impacted daily living from childhood to adulthood and affected relationships and mental and emotional health. Surgery (~50%) and pain medications (~40%) were the most common treatments; nearly all participants (~90%) mentioned the need for disease-modifying treatments. Most patients (~85%) diagnosed as children transitioned to adult care, although there was variability in the transition experience. Some patients (~10%) dropped off during transition; others (~10%) experienced difficulty adjusting to adult specialists.
conclusionsThe real-life perspectives of adult patients and caregivers highlighted that NF1-PN has a profoundly negative impact on QoL and mental health. At the time of the study, the only available treatments for this patient population were surgery or medications for symptom management. Participants identified unmet needs, such as a desire for improved treatment options that halt disease progression and reduce pain while being noninvasive, convenient, and accessible. Improved processes for the transition to adult care are needed.
Indexed as
Identifiers
42814344What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.